John F. Paolini - Sep 1, 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Sep 1, 2024
Transactions value $
-$1,546,830
Form type
4
Date filed
9/4/2024, 08:52 PM
Previous filing
Jul 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +4.12K +8.41% 53.1K Sep 1, 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability -$53.3K -1.99K -3.75% $26.74 51.1K Sep 1, 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise +1.73K +3.37% 52.9K Sep 2, 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability -$22.3K -835 -1.58% $26.74 52K Sep 2, 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise $112K +60.2K +115.72% $1.86 112K Sep 3, 2024 Direct F2
transaction KNSA Class A Ordinary Share Options Exercise $1.81K +475 +0.42% $3.80 113K Sep 3, 2024 Direct F2
transaction KNSA Class A Ordinary Share Sale -$1.54M -59.2K -52.53% $26.09 53.5K Sep 3, 2024 Direct F2, F3
transaction KNSA Class A Ordinary Share Sale -$40.1K -1.48K -2.76% $27.13 52K Sep 3, 2024 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +7K $0.00 7K Sep 1, 2024 Class A Ordinary Share 7K Direct F1, F5
transaction KNSA Share Option Award $0 +36.4K $0.00 36.4K Sep 1, 2024 Class A Ordinary Share 36.4K $26.74 Direct F6
transaction KNSA Restricted Share Unit Options Exercise $0 -2.5K -33.33% $0.00 5K Sep 1, 2024 Class A Ordinary Share 2.5K Direct F1, F7
transaction KNSA Restricted Share Unit Options Exercise $0 -1.62K -25% $0.00 4.87K Sep 1, 2024 Class A Ordinary Share 1.62K Direct F1, F8
transaction KNSA Restricted Share Unit Options Exercise $0 -1.73K -50% $0.00 1.73K Sep 2, 2024 Class A Ordinary Share 1.73K Direct F1, F9
transaction KNSA Share Option Options Exercise $0 -60.2K -100% $0.00 0 Sep 3, 2024 Class A Ordinary Share 60.2K $1.86 Direct F2, F10
transaction KNSA Share Option Options Exercise $0 -475 -1.05% $0.00 44.5K Sep 3, 2024 Class A Ordinary Share 475 $3.80 Direct F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
F3 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
F6 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F7 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F8 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F9 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.
F10 The option is fully vested and exercisable.